Optimizing Intensive Chemotherapy Management in Secondary AML Through Academic Community Collaboration - Episode 5
Assessing Transplant Eligibility and Fitness for Intensive Chemotherapy
Panelists discuss how identifying candidates for allogeneic transplant in secondary acute myeloid leukemia involves a comprehensive assessment of disease characteristics, patient factors, and timing considerations, while also evaluating fitness for intensive chemotherapy induction using specific criteria to guide treatment decisions.
Video Player is loading.
Video content above is prompted by the following:
- Please describe how you identify individuals eligible for allogeneic transplant.
- Discuss when you begin the process of referring a patient for transplant.
- How do you determine if a patient is fit for intensive chemotherapy induction in the frontline setting?
- What are some criteria that you use to determine if patients are eligible for intensive chemotherapy induction?
Related Content:
